Dexmedetomidine Sublingual Film: A New Treatment to Reduce Agitation in Schizophrenia and Bipolar Disorders.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 54, doi. 10.1177/10600280231171179
- By:
- Publication type:
- Article
Works matching IS 10600280 AND DT 2024 AND VI 58 AND IP 1
Results: 13
1
2
Fixed Versus Body-Sized-Based Dosing of Monoclonal Antibodies.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 91, doi. 10.1177/10600280231170650
- By:
- Publication type:
- Article
3
Acknowledgements to AOP Peer Reviewers November 1, 2022 through October 1, 2023.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 96, doi. 10.1177/10600280231208543
- Publication type:
- Article
4
Comparison of Doxycycline or Minocycline to Sulfamethoxazole-Trimethoprim for Treatment of Stenotrophomonas maltophilia Pneumonia.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 21, doi. 10.1177/10600280231166413
- By:
- Publication type:
- Article
5
A Systematic Approach to Understanding Acid-Base Disorders in the Critically Ill.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 65, doi. 10.1177/10600280231165787
- By:
- Publication type:
- Article
6
Pregabalin Does Not Increase Risk of Heart Failure Exacerbation in Patients With Pre-existing Heart Failure.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 15, doi. 10.1177/10600280231165259
- By:
- Publication type:
- Article
7
A Review of Topical Tapinarof for the Treatment of Plaque Psoriasis.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 76, doi. 10.1177/10600280231164775
- By:
- Publication type:
- Article
8
Sacituzumab Govitecan as a Second-Line Treatment in Relapsed/Refractory Metastatic Triple-Negative Breast Cancer Patients: A Systematic Review and Meta-analysis.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 44, doi. 10.1177/10600280231164110
- By:
- Publication type:
- Article
9
Determining the Risk of Elevated Digoxin Concentrations Following Loading Dose in Patients With Acute and Chronic Kidney Disease.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 37, doi. 10.1177/10600280231163256
- By:
- Publication type:
- Article
10
Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 28, doi. 10.1177/10600280231158929
- By:
- Publication type:
- Article
11
Comment: Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 89, doi. 10.1177/10600280221096886
- By:
- Publication type:
- Article
12
Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 86, doi. 10.1177/10600280221096881
- By:
- Publication type:
- Article
13
Effect of Early Administration of Vasopressin on New-Onset Arrhythmia Development in Patients With Septic Shock: A Retrospective, Observational Cohort Study.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 5, doi. 10.1177/10600280221095543
- By:
- Publication type:
- Article